Bright Minds Biosciences Inc. (CSE:DRUG)
Canada
· Delayed Price · Currency is CAD 119.46
-2.08 (-1.71%)
Apr 28, 2026, 3:19 PM EST
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-763.24K CAD
Market Cap
1.19B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Eupraxia Pharmaceuticals | 49 |
| Satellos Bioscience | 21 |
| Helix BioPharma | 7 |
| Sernova Biotherapeutics | 8 |
| Medicenna Therapeutics | 18 |
| BriaCell Therapeutics | 16 |
Bright Minds Biosciences News
- 15 days ago - DRUG Initiates Coverage On Bright Minds Biosciences -- Price Target Announced - GuruFocus
- 7 weeks ago - Bright Minds Biosciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
- 7 weeks ago - Bright Minds Biosciences Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Bright Minds Biosciences to Present at Upcoming Conferences - GlobeNewsWire
- 2 months ago - BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News - GuruFocus
- 3 months ago - Bright Minds Biosciences Announces Closing of US$175 Million Public Offering - GlobeNewsWire
- 3 months ago - Bright Minds Biosciences (DRUG) Prices $175M Public Offering - GuruFocus
- 3 months ago - Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock - GlobeNewsWire